由天津的天士力集团研制生产的复方丹参滴丸,在国内市场省市级城市覆盖率达100％,地市级城市也达到了60％。与此同时,复方丹参滴丸还进入了香港、台湾等东南亚地区和国家,完成了在南美、欧洲、北美等25个国家的市场布局,并被俄罗斯列入处方药目录。产品销售额由4年前的1亿元增长到去年的5亿多元。 在植物药越来越受重视的今天,在年销售额达330亿美元的国际植物药市场上,作为植物药的始祖和集大成者的中药,只占到几乎可以忽略不计的1％的份额,而且大多还只能以食品、保健品、原材料的身 The compound Danshen Diwan developed and produced by Tasly Group in Tianjin has a coverage rate of 100% in provincial and municipal cities in the domestic market and 60% in prefecture-level cities. At the same time, compound Danshen Diwan has also entered the Southeast Asia regions and countries such as Hong Kong, Taiwan and other countries, completed the market distribution in 25 countries including South America, Europe and North America, and was listed as a prescription drug by Russia. Sales of products increased from 100 million yuan four years ago to more than 500 million yuan last year. At a time when plant medicine is gaining more and more attention, in the international market of botanical drugs with annual sales of 33 billion U.S. dollars, only 1% of the total is neglected as the ancestor and master of Chinese herbal medicines. And mostly only with food, health products, raw materials body